Be the first to like this
Oncology Drug Funding is first of its kind funding intelligence report, which provides complete landscape on cancer drug funding starting from early, mid to late stage funding. Released in Sep 2013, it is largest focused updated data available, covering 321 active cancer-focused investors, with past 10 years investment details in more than 500 oncology-focused companies.
Thus It will help to
- First innovative report to provide insights on several new strategic/financial investors willing to fund your company’s growth.
- Clearly identify - who will invest in your business and to which extent.
- Quickly navigate the complete profiles of new and focused Investors and their investment strategies.
- Identify the extent of funding in each round/series to meet your immediate and future needs.
- To design and negotiate on better financial plans to unlock the real value of innovation/assets.
- Directly get in touch with oncology focused Venture Partner through their Linkedin & E-mail ID.
- Explore Top Investors and eliminate your hours of digital search and data curation.
- Access to Numerous deals, structure & size to analyze true value of business model.